2024 Q2 Form 10-Q Financial Statement

#000171893924000085 Filed on May 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $500.4K $573.7K $458.6K
YoY Change 8.59% 25.08% -83.74%
Cost Of Revenue $247.4K $294.6K $217.0K
YoY Change 21.34% 35.79% -68.74%
Gross Profit $253.0K $279.1K $241.7K
YoY Change -1.52% 15.48% -88.64%
Gross Profit Margin 50.55% 48.65% 52.69%
Selling, General & Admin $2.132M $2.492M $1.970M
YoY Change 13.57% 26.49% -36.87%
% of Gross Profit 842.98% 892.82% 815.11%
Research & Development $564.7K $451.8K $632.4K
YoY Change -1.68% -28.55% 28.09%
% of Gross Profit 223.25% 161.9% 261.67%
Depreciation & Amortization $9.000K $184.8K $219.2K
YoY Change -95.19% -15.69% 42.39%
% of Gross Profit 3.56% 66.22% 90.69%
Operating Expenses $3.126M $3.423M $3.038M
YoY Change 18.43% 12.66% -31.91%
Operating Profit -$2.625M -$2.849M -$2.580M
YoY Change 10.2% 10.45% 57.19%
Interest Expense -$16.77K -$18.55K -$11.57K
YoY Change 71.33% 60.33% -131.59%
% of Operating Profit
Other Income/Expense, Net $27.01K $170.7K $32.30K
YoY Change -87.83% 428.45% -163.41%
Pretax Income -$2.598M -$2.679M -$2.547M
YoY Change 19.72% 5.15% 50.55%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.598M -$2.679M -$2.547M
YoY Change 19.72% 5.15% 50.55%
Net Earnings / Revenue -519.26% -466.91% -555.44%
Basic Earnings Per Share -$0.21 -$0.26 -$0.50
Diluted Earnings Per Share -$0.21 -$0.26 -$0.50
COMMON SHARES
Basic Shares Outstanding 10.60M shares 10.10M shares 4.854M
Diluted Shares Outstanding 12.23M shares 10.11M shares 5.045M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $659.5K $816.7K $773.1K
YoY Change -86.9% 5.64% -86.75%
Cash & Equivalents $659.5K $816.7K $773.1K
Short-Term Investments
Other Short-Term Assets $300.7K $377.8K $297.9K
YoY Change -3.84% 26.83% -71.91%
Inventory
Prepaid Expenses $270.3K $300.0K $236.5K
Receivables $517.4K $643.5K $533.5K
Other Receivables $24.92K $16.08K $195.1K
Total Short-Term Assets $1.928M $2.422M $1.800M
YoY Change -68.16% 34.6% -77.76%
LONG-TERM ASSETS
Property, Plant & Equipment $43.51K $47.69K $82.11K
YoY Change -84.32% -41.91% -26.42%
Goodwill $1.249M $1.249M $1.249M
YoY Change 0.0% 0.0%
Intangibles $192.6K $196.0K $238.8K
YoY Change -17.91% 16.7%
Long-Term Investments
YoY Change
Other Assets $41.57K $36.56K $2.066K
YoY Change 273.47% 1669.55% -98.63%
Total Long-Term Assets $3.265M $3.190M $3.361M
YoY Change 1.02% -5.1% 13.47%
TOTAL ASSETS
Total Short-Term Assets $1.928M $2.422M $1.800M
Total Long-Term Assets $3.265M $3.190M $3.361M
Total Assets $5.193M $5.612M $5.161M
YoY Change -44.09% 8.74% -53.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.105M $1.063M $1.365M
YoY Change 42.72% -22.1% 108.79%
Accrued Expenses $1.539M $1.285M $1.191M
YoY Change 92.06% 7.85% -9.66%
Deferred Revenue $182.0K $268.3K $2.747M
YoY Change -90.23% 754.45%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.003M $2.784M $5.893M
YoY Change -34.59% -52.75% 139.05%
LONG-TERM LIABILITIES
Long-Term Debt $953.8K $946.4K $907.6K
YoY Change 3.46% 4.27% 8.29%
Other Long-Term Liabilities $325.2K $338.4K $319.7K
YoY Change 9.15% 5.85% -4.33%
Total Long-Term Liabilities $953.8K $946.4K $907.6K
YoY Change -21.81% 4.27% 8.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.003M $2.784M $5.893M
Total Long-Term Liabilities $953.8K $946.4K $907.6K
Total Liabilities $4.282M $4.069M $7.120M
YoY Change -28.3% -42.85% 95.75%
SHAREHOLDERS EQUITY
Retained Earnings -$56.13M -$53.53M -$41.85M
YoY Change 27.91% 44.81%
Common Stock $113.8K $101.0K $51.22K
YoY Change 97.2% -77.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $750.4K $1.382M -$2.120M
YoY Change
Total Liabilities & Shareholders Equity $5.193M $5.612M $5.161M
YoY Change -44.09% 8.74% -53.31%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.598M -$2.679M -$2.547M
YoY Change 19.72% 5.15% 50.55%
Depreciation, Depletion And Amortization $9.000K $184.8K $219.2K
YoY Change -95.19% -15.69% 42.39%
Cash From Operating Activities -$1.599M -$2.160M -$155.0K
YoY Change -53.33% 1293.55% -86.4%
INVESTING ACTIVITIES
Capital Expenditures $207.1K $2.777K $191.2K
YoY Change 1.84% -98.55% 1801.08%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$207.1K -$156.0K -$191.2K
YoY Change -219.05% -18.44% -21.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.656M -$22.50K -103.1K
YoY Change -77.97% -78.17% -102.79%
NET CHANGE
Cash From Operating Activities -1.599M -$2.160M -155.0K
Cash From Investing Activities -207.1K -$156.0K -191.2K
Cash From Financing Activities 1.656M -$22.50K -103.1K
Net Change In Cash -150.4K -$2.324M -481.4K
YoY Change -103.53% 382.79% -120.39%
FREE CASH FLOW
Cash From Operating Activities -$1.599M -$2.160M -$155.0K
Capital Expenditures $207.1K $2.777K $191.2K
Free Cash Flow -$1.806M -$2.163M -$346.2K
YoY Change -50.24% 524.66% -69.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10099672 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9198089 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10099672 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9143355 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
100997 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
91434 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
54734 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54641448 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54375622 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1543391 usd
CY2023 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense
CY2024Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
50000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
896026 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
826781 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2422280 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4697942 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1476193 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472374 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1248664 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1248664 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
196044 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
223690 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47694 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56436 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
184642 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
164740 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
69727 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81236 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
162130 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2783926 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2714250 usd
CY2024Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
254076 usd
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
256536 usd
CY2024Q1 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
14511 usd
CY2023Q4 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
40317 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
946395 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
953877 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84288 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53771 usd
CY2024Q1 us-gaap Liabilities
Liabilities
4068685 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3978434 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
171361 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
139670 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53531854 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50853285 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1381952 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3753441 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
161439 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
161439 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1543391 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3914880 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5612076 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7893314 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
451842 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
632369 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2491693 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1969875 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
184801 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
219181 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
3422934 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3038383 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2849258 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2579750 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18549 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10231 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2460 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1340 usd
CY2024Q1 idai Others Non Operating Income
OthersNonOperatingIncome
193114 usd
CY2023Q1 idai Others Non Operating Income
OthersNonOperatingIncome
44614 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
6336 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
743 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
170689 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32300 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2678569 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2547450 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2678569 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2547450 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2678569 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10111993 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2678569 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2547450 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
31691 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41442 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31691 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-41442 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2646878 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2588892 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2646878 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2588892 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625144 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 idai Conversion Of Treasury Stock In Relation To Vested Restricted Stock Units Value
ConversionOfTreasuryStockInRelationToVestedRestrictedStockUnitsValue
-75343 usd
CY2023Q1 idai Reverse Stock Split Rounding
ReverseStockSplitRounding
0 usd
CY2023Q1 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
18547 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59574 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41442 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1958970 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3914880 usd
CY2024Q1 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-22497 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
297886 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
31691 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2678569 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2678569 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184801 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219181 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
297886 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
59574 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2460 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1340 usd
CY2024Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
0 usd
CY2023Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
18547 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
14511 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
9904 usd
CY2024Q1 idai Non Cash Lease Expense
NonCashLeaseExpense
41267 usd
CY2023Q1 idai Non Cash Lease Expense
NonCashLeaseExpense
66759 usd
CY2024Q1 idai Non Cash Write Off
NonCashWriteOff
-162130 usd
CY2023Q1 idai Non Cash Write Off
NonCashWriteOff
0 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-969 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-897 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42848 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-474911 usd
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-28004 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-696 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
69245 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-123177 usd
CY2024Q1 idai Increase Decrease In Deferred Financing Costs
IncreaseDecreaseInDeferredFinancingCosts
50000 usd
CY2023Q1 idai Increase Decrease In Deferred Financing Costs
IncreaseDecreaseInDeferredFinancingCosts
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7091 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-168788 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
419887 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
140688 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
91294 usd
CY2024Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
13965 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
37962 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
257450 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
935289 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-41741 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-66546 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2157635 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-154578 usd
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
143917 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
167668 usd
CY2024Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
9268 usd
CY2023Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
23563 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2777 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-155962 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191231 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000 usd
CY2024Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
22497 usd
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
75343 usd
CY2024Q1 idai Principal Payment On Derivatives
PrincipalPaymentOnDerivatives
0 usd
CY2023Q1 idai Principal Payment On Derivatives
PrincipalPaymentOnDerivatives
29715 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22497 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-103058 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12040 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32513 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2324055 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-481380 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3140747 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1254494 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
816692 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
773114 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
570 usd
CY2024Q1 idai Adjustment To Operating Lease Right Of Use Assets Related To Renewed Leases
AdjustmentToOperatingLeaseRightOfUseAssetsRelatedToRenewedLeases
61169 usd
CY2023Q1 idai Adjustment To Operating Lease Right Of Use Assets Related To Renewed Leases
AdjustmentToOperatingLeaseRightOfUseAssetsRelatedToRenewedLeases
0 usd
CY2024Q1 idai Adjustment To Operating Lease Operating Lease Liabilities Related To Renewed Leases
AdjustmentToOperatingLeaseOperatingLeaseLiabilitiesRelatedToRenewedLeases
60749 usd
CY2023Q1 idai Adjustment To Operating Lease Operating Lease Liabilities Related To Renewed Leases
AdjustmentToOperatingLeaseOperatingLeaseLiabilitiesRelatedToRenewedLeases
0 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
82982 usd
CY2024Q1 idai Non Cash Activity Of Operating Lease Liabilities Related To Terminated Leases
NonCashActivityOfOperatingLeaseLiabilitiesRelatedToTerminatedLeases
0 usd
CY2023Q1 idai Non Cash Activity Of Operating Lease Liabilities Related To Terminated Leases
NonCashActivityOfOperatingLeaseLiabilitiesRelatedToTerminatedLeases
77648 usd
CY2024Q1 idai Non Cash Activity Of Prepaid Rent Expense Reclassified Upon Termination Of Leases
NonCashActivityOfPrepaidRentExpenseReclassifiedUponTerminationOfLeases
0 usd
CY2023Q1 idai Non Cash Activity Of Prepaid Rent Expense Reclassified Upon Termination Of Leases
NonCashActivityOfPrepaidRentExpenseReclassifiedUponTerminationOfLeases
5335 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2680000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2160000 usd
CY2024Q1 idai Working Capital In Business
WorkingCapitalInBusiness
360000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53530000 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Major Customers and Concentration of Risks —</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of Cash and cash equivalents, and Accounts receivable. We maintain our Cash and cash equivalents with high-quality financial institutions, mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of March 31, 2024 and December 31, 2023, the Company had $318,923 and $2,620,765 in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three customers represented 91.01% or 40.51%, 37.58%, and 12.92% of the balance of total Accounts receivable as of March 31, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had not experienced any significant losses on its Accounts receivable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company sold to primarily three customers which made up approximately 94.63% of total Net revenue, and consisted of 58.08%, 27.38%, and 9.17% from an S&amp;P 500 Bank, Mastercard and Triton, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the three months ended March 31, 2023, the Company sold to primarily three customers which made up approximately 78.77% of total Net revenue, and consisted of 40.14%, 25.08%, and 13.55% from an S&amp;P 500 Bank, Mastercard, and FIS, respectively.</span></div>
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
19000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
12000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
573676 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458633 usd
CY2024Q1 idai Class Of Warrant Or Right Consideration Transferred
ClassOfWarrantOrRightConsiderationTransferred
1000000 usd
CY2024Q1 idai Percentage Of Discount Of Future Issuance Of Preferred Stock
PercentageOfDiscountOfFutureIssuanceOfPreferredStock
0.20
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000 usd
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000 usd
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
50000 usd
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6418 shares
CY2024Q1 idai Fair Value Adjustment Of Warrants Rounded
FairValueAdjustmentOfWarrantsRounded
-3000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5564199 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6446199 shares
CY2023Q2 idai Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
1279700 shares
CY2023Q4 idai Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
1573330 shares
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
300002 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
216875 usd
CY2024Q1 us-gaap Prepaid Rent
PrepaidRent
27803 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
28400 usd
CY2024Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
130090 usd
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
116095 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
66135 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
102151 usd
CY2024Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
371996 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
363260 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
896026 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
826781 usd
CY2024Q1 idai Capitalized Computer Software Useful Life
CapitalizedComputerSoftwareUsefulLife
P5Y
CY2024Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4043786 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3901801 usd
CY2024Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2567593 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2429427 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1476193 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472374 usd
CY2024Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
138000 usd
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
141000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
178091 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
180066 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
130397 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123630 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47694 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56436 usd
CY2024Q1 us-gaap Depreciation
Depreciation
10000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
42000 usd
CY2024Q1 idai Compensation Payable
CompensationPayable
447306 usd
CY2023Q4 idai Compensation Payable
CompensationPayable
377403 usd
CY2024Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
32948 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
26863 usd
CY2024Q1 idai Accrued Employee Taxes
AccruedEmployeeTaxes
769653 usd
CY2023Q4 idai Accrued Employee Taxes
AccruedEmployeeTaxes
624525 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34671 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
115099 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1284578 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1143890 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
562124 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
554481 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
366080 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
330791 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
196044 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
223690 usd
CY2024Q1 idai Number Of Finite Lived Intangible Assets
NumberOfFiniteLivedIntangibleAssets
20 patent
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
86105 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
78133 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
31659 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
147 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
196044 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2678569 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10111993 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10111993 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
8505943 usd
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
2408969 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
387109 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y5M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11890 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.28
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1230 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.25
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4186 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.73
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
393583 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.27
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y11M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3825 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.57
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1425 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.21
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
395983 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.24
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M19D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
395983 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.24
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M19D
CY2024Q1 idai Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.61
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.00
CY2024Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
2000 usd
CY2023Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
4000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
54734 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
297886 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59574 usd
CY2024Q1 idai Minimum Lease Commitments
MinimumLeaseCommitments
0 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M29D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2024Q1 idai Number Of Leases Terminated
NumberOfLeasesTerminated
0 lease
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
184642 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
164740 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
69727 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81236 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84288 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53771 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
154015 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
135007 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year One
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearOne
57391 usd
CY2024Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year One
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne
4444 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
61835 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Two
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearTwo
57386 usd
CY2024Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year Two
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo
3170 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
60556 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Three
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearThree
22455 usd
CY2024Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year Three
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree
1137 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
23592 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Four
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearFour
8556 usd
CY2024Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year Four
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour
607 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9163 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount After Year Four
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountAfterYearFour
8227 usd
CY2024Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount After Year Four
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFour
172 usd
CY2024Q1 idai Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
8399 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
154015 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9530 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
163545 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
39877 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
83034 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
11936 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
21935 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
51813 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
104969 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
41741 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
66546 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
162000 usd
CY2023Q1 idai Financial Liability Obligation Termination Notice Term
FinancialLiabilityObligationTerminationNoticeTerm
P30D

Files In Submission

Name View Source Status
0001718939-24-000085-index-headers.html Edgar Link pending
0001718939-24-000085-index.html Edgar Link pending
0001718939-24-000085.txt Edgar Link pending
0001718939-24-000085-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idai-20240331.htm Edgar Link pending
idai-20240331.xsd Edgar Link pending
idai-20240331xex311.htm Edgar Link pending
idai-20240331xex312.htm Edgar Link pending
idai-20240331xex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
idai-20240331_cal.xml Edgar Link unprocessable
idai-20240331_def.xml Edgar Link unprocessable
idai-20240331_lab.xml Edgar Link unprocessable
idai-20240331_pre.xml Edgar Link unprocessable
idai-20240331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable